Navigating the Regulatory Requirements of Pediatric Research
Schulman IRB Vice Chair Nathan Lee discusses the specific OHRP and FDA regulations regarding research in pediatric populations and their impact on proposed pediatric research.
The industry’s choice for
central and local IRB services.
By combining quality reviews with global consulting services, uniquely responsive client service and proprietary, Part 11 compliant technology tools, we are able to both improve human subject protection and allow our clients to reach their business goals.
We've been serving the clinical trial industry since 1983.
Our technology tools deliver unparalleled visibility and efficiency.
We complete thorough, ethical reviews as swiftly as possible.
The Schulman IRB Webinar Series offers timely information to study sponsors, CRO representatives, investigators and institutional personnel in an engaging, easy-to-parse format.
CLICK HERE to see our full webinar archive, as well as to register for upcoming sessions.
Michael Woods shares his thoughts about the future of cancer in PharmaVOICE's November/December issue "Trending 2017: The Cancer Moonshot."Read More